Results 121 to 130 of about 824 (137)

Priorities in Parkinson's disease research

Nature Reviews Drug Discovery, 2011
Wassilios G Meissner, Thomas Gasser, Olivier Rascol   +2 more
exaly  

Parkinson's disease and cancer: two wars, one front

Nature Reviews Cancer, 2011
Michael J Devine, Hélène Plun-Favreau, Nicholas W Wood   +2 more
exaly  

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs

Nature Reviews Drug Discovery, 2018
Delphine Charvin, Olivier Rascol, Hauser Robert A   +2 more
exaly  

Parkinson disease

Nature Reviews Disease Primers, 2017
Werner Poewe, Klaus Seppi, Caroline M Tanner   +2 more
exaly  

Levodopa and the Progression of Parkinson's Disease

New England Journal of Medicine, 2004
David Oakes, Karl Kieburtz, Anthony E Lang   +2 more
exaly  

New leads for Parkinson's disease

Nature Reviews Drug Discovery, 2010
Kingwell Katie
exaly  

Rivastigmine for Dementia Associated with Parkinson's Disease

New England Journal of Medicine, 2004
Dag Aarsland, Alberto Albanese, E Jane Byrne   +2 more
exaly  

Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene

New England Journal of Medicine, 2000
Christoph B Lucking, Giuseppe De Michele, Thomas Gasser   +2 more
exaly  

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease

New England Journal of Medicine, 1998
Patricia Limousin, Paul Krack, Pierre Pollak   +2 more
exaly  

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease

New England Journal of Medicine, 2001
Curt R Freed, Robert E Breeze, John Q Trojanowski   +2 more
exaly